February 14, 2022

Dr. Jonathan Jackson – Clinical Research and Stigma in Communities of Color

Dr. Jonathan Jackson – Clinical Research and Stigma in Communities of Color

About This Episode

Every February, Black History Month, the U.S. honors the contributions and sacrifices of African Americans who have helped shaped our nation's history. This year's theme, black health and wellness, pays homage to medical scholars and healthcare providers. 

BrainStorm host, Meryl Comer, and guest, Dr. Jonathan Jackson, a cognitive neuroscientist on the faculty at Harvard Medical School with a specialty in the early detection of Alzheimer's, discuss the barriers to clinical research for people and communities of color. In addition, Alzheimer’s and related dementias carry their own stigma in the general population, which becomes even more complex in communities of color. Hear their timely conversation.

Support the show (https://www.usagainstalzheimers.org)

BrainStorm Feed

100

2025 Year in Review and Predictions for 2026 with George Vradenburg

George Vradenburg, Chairman and Founder of UsAgainstAlzheimer's, sits down with host Meryl Comer for a comprehensive look at the state of Alzheimer's research, advocacy, and care in 2025.
LISTEN NOW
99

The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials.
LISTEN NOW
98

The Future of Alzheimer's Trials: Bringing Cutting-Edge Research to Every Community - John Dwyer, CEO of The Global Alzheimer's Platform

John Dwyer, CEO of the Global Alzheimer's Platform (GAP), highlights GAP's innovations in improving the participant experience through streamlining visits, personalized feedback, and bringing mobile trials directly to small communities.
LISTEN NOW